Drugs / Vantaflu
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01222403 | Oct 2010 → Oct 2014 | influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VANTAFLU | “Sandoz Korea Vaccine MF59-adjuvanted Influenza Subunit Vaccine VANTAFLU®” NCT01222403 ↗ |